CSL BEHRING LLC for CSL BEHRING LLC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 4724--The Medicare IVIG Access Enhancement Act--Lobbied in support of this legislation that would create a home infusion benefit under Medicare Part B for IVIG when used in the treatment of CIDP. Preserving Access to Orphan Drugs Act--Exploration of fine tuning orphan drug exclusion from the annual pharmaceutical fee Educating congressional staff specific to the value of drug therapies (drug pricing, value, access to therapies, etc.) as part of Administration drug pricing blueprint and request for information.
Foreign entity interest: CSL Limited, identified on form LD-1, has an interest in the activities of its U.S. subsidiary CSL Behring on all issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK COLLINS | — |
| JULIA GRANT | — |
| DENNIS JACKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.